Measles and Solid Organ Transplantation: Diagnosis, Treatment, and Prevention
- PMID: 40590830
- DOI: 10.1111/tid.70066
Measles and Solid Organ Transplantation: Diagnosis, Treatment, and Prevention
Abstract
The recent international resurgence of measles has led to significant public health concerns and poses significant risks to immunocompromised patients, including those who have undergone solid organ transplantation (SOT). SOT recipients may present atypically and are at an increased risk of severe complications of measles infection, underscoring the importance of preventative measures. This review summarizes contemporary data regarding measles transmission, the clinical presentation, diagnosis, and treatment of SOT recipients, as well as strategies for measles prevention, infection control considerations, postexposure prophylaxis, and opportunities for the mitigation of donor-derived measles and measles vaccine viruses.
Keywords: donor‐derived infection; measles; postexposure prophylaxis; solid organ transplantation; vaccination.
© 2025 Wiley Periodicals LLC.
References
-
- World Health Organization. Measles. Accessed: March 12, 2025, https://www.who.int/health‐topics/measles#tab=tab_1.
-
- A. Dabbagh, R. L. Laws, C. Steulet, et al., “Progress toward Regional Measles Elimination—Worldwide, 2000–2017,” Morbidity and Mortality Weekly Report 67 (2018): 1323–1329.
-
- J. M. Hubschen, I. Gouandjika‐Vasilache, and J. Dina, “Measles,” Lancet 399 (2022): 678–690.
-
- G. Kaur, M. C. Danovaro‐Holliday, G. Mwinnyaa, et al., “Routine Vaccination Coverage—Worldwide, 2022,” Morbidity and Mortality Weekly Report 72 (2023): 1155–1161.
-
- C. E. Stein, M. Birmingham, M. Kurian, P. Duclos, and P. Strebel, “The Global Burden of Measles in the Year 2000–A Model That Uses Country‐specific Indicators,” Journal of Infectious Diseases 187, no. 1 (2003): S8–14.